Artica Therapeutics

Seed
artica-tx.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Nov 2, 2023
Investors Undisclosed
Decision Makers 6 Verified

About Artica Therapeutics

Artica is leveraging covalency as key differentiator to deliver oral “ antibody-in-a-pill ” solutions for patients suffering from immune mediated conditions

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website artica-tx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Artica Therapeutics.

Funding History

1 Round
Seed · Nov 2, 2023

Founders & Leadership

3

Ad IJzerman

founder

Work email & phone locked Unlock →

Arwin Ridder

Founder and COO

Work email & phone locked Unlock →

Tjeerd Barf

Founder, CEO & executive board member

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts